MARKET

BLI

BLI

Berkeley Lights, Inc.
NASDAQ

Real-time Quotes | Nasdaq Last Sale

46.56
+0.03
+0.06%
Closed 16:14 07/29 EDT
OPEN
46.97
PREV CLOSE
46.53
HIGH
47.39
LOW
46.05
VOLUME
252.34K
TURNOVER
--
52 WEEK HIGH
113.53
52 WEEK LOW
35.51
MARKET CAP
2.84B
P/E (TTM)
-60.6329
1D
5D
1M
3M
1Y
5Y
Were Hedge Funds Right About Berkeley Lights, Inc. (BLI)?
Out of thousands of stocks that are currently traded on the market, it is difficult to identify those that will really generate strong returns. Hedge funds and institutional investors spend millions of dollars on analysts with MBAs and PhDs, who are indust...
Insider Monkey · 1d ago
Berkeley Lights Inc (BLI) CEO Eric Hobbs Sold $729,585 of Shares
GuruFocus News · 6d ago
Berkeley Lights enters into strategic partnership with Thermo Fisher Scientific
Digital cell biology company Berkeley Lights (BLI) has entered into a strategic collaboration with Thermo Fisher Scientific (TMO).The companies are developing a next-generation workflow using the Berkeley Lights Platform to
Seekingalpha · 07/21 13:38
BRIEF-Berkeley Lights Announces Collaboration To Improve Gene Therapy Viral Vector Development And Manufacturing
reuters.com · 07/21 13:37
Berkeley Lights announces technology collaboration to accelerate and improve gene therapy viral vector development and manufacturing
EMERYVILLE, Calif., July 21, 2021 (GLOBE NEWSWIRE) -- Berkeley Lights, Inc. (Nasdaq: BLI) today announced a strategic collaboration with Thermo Fisher Scientific aimed at addressing challenges in commercial-scale viral vector manufacturing. The partnership...
GlobeNewswire · 07/21 13:00
Berkeley Lights to Report Second Quarter 2021 Financial Results on August 11, 2021
Berkeley Lights, Inc. (Nasdaq: BLI), a leader in Digital Cell Biology, today announced the company will be reporting financial results for the second quarter 2021 before market open on Wednesday, August 11, 2021. Company management will be webcasting a cor...
GlobeNewswire · 07/13 20:05
BRIEF-Berkeley Lights Inc Enters Into An Amended And Restated Loan And Security Agreement
reuters.com · 07/07 21:50
Keybanc Downgrades Berkeley Lights to Sector Weight
Keybanc analyst Paul Knight downgrades Berkeley Lights (NASDAQ:BLI) from Overweight to Sector Weight.
Benzinga · 06/29 08:39
More
Forecast
Actual (USD)
Estimate (USD)
Income StatementMore
Net Income (USD)
YoY (%)
Balance SheetMore
Total Assets (USD)
Total Liabilities (USD)
Debt to Asset (%)
Cash FlowMore
Operating (USD)
YoY (%)
Learn about the latest financial forecast of BLI. Analyze the recent business situations of Berkeley Lights, Inc. through EPS, BVPS, FPS, and other data. This information may help you make smarter investment decisions.
Analyst Rating

Based on 7 analysts

Buy

Disclaimer: The analysis information is for reference only and does not constitute an investment recommendation.

Analyst Price Target
The average BLI stock price target is 79.50 with a high estimate of 100.00 and a low estimate of 70.00.
EPS
Institutional Holdings
Institutions: 153
Institutional Holdings: 37.39M
% Owned: 61.35%
Shares Outstanding: 60.94M
TypeInstitutionsShares
Increased
64
16.09M
New
62
3.51M
Decreased
18
4.42M
Sold Out
22
564.01K
  • Performance
  • Asset Allocation
  • Dividend History
No Data
Industry
Medical Equipment, Supplies & Distribution
+0.52%
Healthcare Equipment & Supplies
+0.72%
Key Executives
Chairman/Director
Gregory Lucier
Chief Executive Officer/Director
Eric Hobbs
Co-Founder/Independent Director
Igor Khandros
Chief Financial Officer/Chief Accounting Officer
Kurt Wood
Chief Technology Officer
Keith Breinlinger
General Counsel
Stuart Merkadeau
Other
Kevin Chapman
Director
John Chiminski
Director
James Rothman
Independent Director
Sarah Boyce
Independent Director
Michael Moritz
Independent Director
Elizabeth Nelson
No Data
About BLI
Berkeley Lights, Inc. is a Digital Cell Biology company focused on enabling and accelerating the rapid development and commercialization of biotherapeutics and other cell-based products. The Company has developed the Berkeley Lights Platform to provide the advanced environment for rapid functional characterization of single cells at scale. The Berkeley Lights Platform consists of advanced automated systems that analyze live cells using consumables and application and workflow software to deliver robust single cell data. Its platform characterizes the performance of cells relevant to the desired cell-based product early in the process and then connects this phenotypic data to the genetic code for each cell. The Berkeley Lights Platform is a fully integrated, end-to-end solution, comprised of consumables, including its OptoSelect chips and reagent kits, advanced automation systems and advanced application and workflow software.

Webull offers kinds of Berkeley Lights Inc stock information, including NASDAQ:BLI real-time market quotes, financial reports, professional analyst ratings, in-depth charts, corporate actions, BLI stock news, and many more online research tools to help you make informed decisions.

You can practice and explore trading BLI stock methods without spending real money on the virtual paper trading platform.